BACKGROUND: The purpose is to assess the short- and mid-term outcomes of microwave ablation (MWA) of @entity703 in selected @entity1 . METHODS: From August 2012 to February 2015, 29 @entity703 in 23 @entity1 (17 male, 6 female, mean age 75 years) were treated by percutaneous MWA under imaging guidance. The @entity5 were 1-4.7 cm in diameter (mean size, 2.7 cm). Therapeutic effects were assessed at follow-up with magnetic resonance imaging (MRI). All @entity1 were followed up for 2-25 months (mean, 12.2 months) to observe the therapeutic effects and complications. Changes in renal function at day 1 after treatment were statistically analyzed using the Student paired t-test or the paired Wilcoxon test. RESULTS: Technical success was achieved in all cases. One severe @entity548 complication post-procedure occurred leading to @entity204 . No other unexpected side effects were observed after the MWA procedures. Clinical effectiveness was 100%. None of the @entity1 showed recurrence on MRI imaging follow-up. No significant changes in renal function were noted after treatment (P=0.57). CONCLUSIONS: Our preliminary study demonstrates that the use of MWA for the treatment of @entity703 can be applied as safely and efficiently as other ablative techniques in selected @entity1 not eligible for surgery.

Image-guided percutaneous microwave ablation of XXXX : short- and mid-term outcomes.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumours'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity703 :: ('MESH:D007680', 'Disease') :: ['renal tumours', 'small renal tumours']
@entity703 :: (MESH:D007680,Disease) :: ['small renal tumours']
